Stablepharma

Recent Finacing

Grant

Recent Raise

$2.9M

Stablepharma develops StablevaX™, a GMP-scalable platform that converts vaccines, therapeutics, and diagnostics into thermostable, fridge-free formulations, collaborating with manufacturers, academics, and NGOs and advancing SPVX02 into Phase 1 trials.

Founded 2012

Bath and North East Somerset, United Kingdom

11-50

Private

stablepharma.com